Markers like Epidermal Growth Factor Receptor (EGFR) amplifications, Telomerase Reverse Transcriptase (TERT) promoter mutations, combined whole chromosome 7 gain, and combined whole chromosome 10 loss are crucial for diagnosing glioblastoma IDH wildtype [32]. Here, EGFR is linked to glioblastoma.